1308380-31-5

Basic information

• Product Name: 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione
• Synonyms: 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione
• CAS NO: 1308380-31-5
• Molecular Weight: 476.474
• Mol File: 1308380-31-5.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione(1308380-31-5)
• EPA Substance Registry System: 5-(4-benzyl-piperazin-1-yl)-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-1H-pyrimidine-2,4-dione(1308380-31-5)

Safety Data

• Hazardous Substances Data: 1308380-31-5(Hazardous Substances Data)

Upstream product

• 2759-28-6 1-phenylmethylpiperazine 
• 830346-48-0 5-bromo-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methylpyrimidine-2,4-(1H,3H)-dione 

Downstream Products

• 1308378-96-2 (R)-4-((1-(3-fluoro-5-methylphenyl)-2-(3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)-2,3-dihydropyrimidin-1(6H)-yl)ethyl)amino)butanoic acid 
• 1308378-99-5 (R)-4-((1-(5-fluoro-2-methoxyphenyl)-2-(3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)-2,3-dihydropyrimidin-1(6H)-yl)ethyl)amino)butanoic acid 
• 1308379-02-3 (R)-4-((2-(3-(2-fluoro-6-(trifluoromethyl)benzyl)-4-methyl-2,6-dioxo-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)-2,3-dihydropyrimidin-1(6H)-yl)-1-(2-methoxyphenyl)ethyl)amino)butanoic acid 
• 1308378-51-9 (R)-3-(2-amino-2-(3-fluoro-5-methylphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308378-49-5 (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308378-48-4 (R)-3-(2-amino-2-(2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308376-62-6 (R)-3-(2-amino-2-phenylethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-5-(4-((5-(trifluoromethyl)furan-2-yl)methyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308375-83-8 (S)-3-(2-amino-2-(3-fluoro-5-methylphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308376-93-3 (R)-3-(2-amino-2-(3-fluoro-5-methylphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308375-84-9 (S)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308376-92-2 (R)-3-(2-amino-2-(5-fluoro-2-methoxyphenyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl) benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 
• 1308378-45-1 3-[2-amino-2-(3-fluoro-phenyl)-ethyl]-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-5-[4-(3-nitro-benzyl)-piperazin-1-yl]-1H-pyrimidine-2,4-dione 
• 1308378-44-0 3-[(R)-2-amino-2-(4-fluoro-phenyl)-ethyl]-1-(2-fluoro-6-trifluoromethyl-benzyl)-6-methyl-5-[4-(3-nitro-benzyl)-piperazin-1-yl]-1H-pyrimidine-2,4-dione 
• 1308378-42-8 3-(2-amino-2-(m-tolyl)ethyl)-1-(2-fluoro-6-(trifluoromethyl)benzyl)-6-methyl-5-(4-(3-nitrobenzyl)piperazin-1-yl)pyrimidine-2,4(1H,3H)-dione 

Relevant articles and documents

Synthesis and biological evaluation of 3-(2-aminoethyl) uracil derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists

We investigated a series of uracil analogues by introducing various substituents on the phenyl ring of the N-3 aminoethyl side chain and evaluated their antagonistic activity against human gonadotropin-releasing hormone (GnRH) receptors. Analogues with su

Gonadotropin Releasing Hormone Receptor Antagonist, Preparation Method Thereof And Pharmaceutical Composition Comprising The Same

Disclosed are compounds useful as gonadotrophin-releasing hormone (“GnRH”) receptor antagonist.